secwatch / observer
8-K filed April 25, 2023, 7:59 PM ET ticker GDRX CIK 0001809519
leadership confidence medium sentiment neutral materiality 0.75

GoodRx appoints Scott Wagner as Interim CEO; co-founders transition to Chairman and Chief Mission Officer

GoodRx Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Scott Wagner

Interim Chief Executive Officer
GDRX · GoodRx Holdings, Inc.
Effective
2023-04-25
Filed
April 25, 2023, 7:59 PM ET
the Company’s Board of Directors (the “Board”) appointed Scott Wagner as Interim Chief Executive Officer of the Company (principal executive officer), effective April 25, 2023.
Role change

Douglas Hirsch

Chief Mission Officer
GDRX · GoodRx Holdings, Inc.
Effective
2023-04-25
Filed
April 25, 2023, 7:59 PM ET
Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively
Role change

Trevor Bezdek

Chairman
GDRX · GoodRx Holdings, Inc.
Effective
2023-04-25
Filed
April 25, 2023, 7:59 PM ET
Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GoodRx Holdings, Inc. reported financial results for the first quarter ended March 31, 2023.

Period
the first quarter ended March 31, 2023
Result
reported results
Exact text from the filing
On April 25, 2023, GoodRx Holdings, Inc. (the “Company”) issued a press release in connection with the executive leadership transition described in Item 5.02 of this Current Report on Form 8-K which addresses the Company’s financial performance for the first quarter ended March 31, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Wagner was appointed as Interim Chief Executive Officer at GoodRx Holdings, Inc..

Action
appointed
Role
Interim Chief Executive Officer
Exact text from the filing
the Company’s Board of Directors (the “Board”) appointed Scott Wagner as Interim Chief Executive Officer of the Company (principal executive officer), effective April 25, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Douglas Hirsch changed role as Chief Mission Officer at GoodRx Holdings, Inc..

Action
transitioned
Role
Chief Mission Officer
Exact text from the filing
Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Trevor Bezdek changed role as Chairman at GoodRx Holdings, Inc..

Action
transitioned
Role
Chairman
Exact text from the filing
Messrs. Bezdek and Hirsch will each remain executive officers of the Company, serving as Chairman and Chief Mission Officer, respectively
View on SEC.gov

Browse all earnings releases →

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-115360
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.